Cargando…

Animal Models of Phage Therapy

Amidst the rising tide of antibiotic resistance, phage therapy holds promise as an alternative to antibiotics. Most well-designed studies on phage therapy exist in animal models. In order to progress to human clinical trials, it is important to understand what these models have accomplished and dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Penziner, Samuel, Schooley, Robert T., Pride, David T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876411/
https://www.ncbi.nlm.nih.gov/pubmed/33584632
http://dx.doi.org/10.3389/fmicb.2021.631794
_version_ 1783649966684635136
author Penziner, Samuel
Schooley, Robert T.
Pride, David T.
author_facet Penziner, Samuel
Schooley, Robert T.
Pride, David T.
author_sort Penziner, Samuel
collection PubMed
description Amidst the rising tide of antibiotic resistance, phage therapy holds promise as an alternative to antibiotics. Most well-designed studies on phage therapy exist in animal models. In order to progress to human clinical trials, it is important to understand what these models have accomplished and determine how to improve upon them. Here we provide a review of the animal models of phage therapy in Western literature and outline what can be learned from them in order to bring phage therapy closer to becoming a feasible alternative to antibiotics in clinical practice.
format Online
Article
Text
id pubmed-7876411
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78764112021-02-12 Animal Models of Phage Therapy Penziner, Samuel Schooley, Robert T. Pride, David T. Front Microbiol Microbiology Amidst the rising tide of antibiotic resistance, phage therapy holds promise as an alternative to antibiotics. Most well-designed studies on phage therapy exist in animal models. In order to progress to human clinical trials, it is important to understand what these models have accomplished and determine how to improve upon them. Here we provide a review of the animal models of phage therapy in Western literature and outline what can be learned from them in order to bring phage therapy closer to becoming a feasible alternative to antibiotics in clinical practice. Frontiers Media S.A. 2021-01-28 /pmc/articles/PMC7876411/ /pubmed/33584632 http://dx.doi.org/10.3389/fmicb.2021.631794 Text en Copyright © 2021 Penziner, Schooley and Pride. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Penziner, Samuel
Schooley, Robert T.
Pride, David T.
Animal Models of Phage Therapy
title Animal Models of Phage Therapy
title_full Animal Models of Phage Therapy
title_fullStr Animal Models of Phage Therapy
title_full_unstemmed Animal Models of Phage Therapy
title_short Animal Models of Phage Therapy
title_sort animal models of phage therapy
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876411/
https://www.ncbi.nlm.nih.gov/pubmed/33584632
http://dx.doi.org/10.3389/fmicb.2021.631794
work_keys_str_mv AT penzinersamuel animalmodelsofphagetherapy
AT schooleyrobertt animalmodelsofphagetherapy
AT pridedavidt animalmodelsofphagetherapy